Tumor Biology's struggle to survive: A tough lesson for cancer and oncology research journals
References
- https://www.isobm.org/tumor-biology/aims-and-scopes/
- https://www.iospress.com/catalog/journals/tumor-biology
- Chechlinska M. Tumor Biology: A new chapter. Tumor Biol 2018; 40(1): 1. doi: <a href="https://doi.org/10.1177/1010428317748815" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1177/1010428317748815</a>
- https://content.iospress.com/journals/tumor-biology/43/1
- https://publicationethics.org/members
- Wan Y, Fei X, Wang Z, Jiang D, Chen H, Wang M, Zhou S. Retracted - miR-423-5p knockdown enhances the sensitivity of glioma stem cells to apigenin through the mitochondrial pathway. Tumor Biol 2017; 39(4): 1–10. doi: <a href="https://doi.org/10.1177/1010428317695526" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1177/1010428317695526</a>
- Peng T, Zhou L, Qi H, Wang G, Luan Y, Zuo L. Retracted - MiR-592 functions as a tumor suppressor in glioma by targeting IGFBP2. Tumor Biol 2017; 39(7): 1–9. doi: <a href="https://doi.org/10.1177/1010428317719273" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1177/1010428317719273</a>
- Teixeira da Silva JA. Paper mill-derived cancer research: The improbability of prostate cancer in women, and ovarian and breast cancer in men. Nowotwory J Oncol 2021; 71(4): 255–256. doi: <a href="https://doi.org/10.5603/NJO.a2021.0039" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.5603/NJO.a2021.0039</a>
- Feldwisch-Drentrup H. Journal that holds record for retracted papers also has a problem with editorial board members. Science 2017, doi: <a href="https://doi.org/10.1126/science.aal1210" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1126/science.aal1210</a>
- Stigbrand T. Retraction Note to multiple articles in Tumor Biology. Tumor Biol 2017; no vol(issue): 1–6. doi: <a href="https://doi.org/10.1007/s13277-017-5487-6" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.1007/s13277-017-5487-6</a>
- https://retractionwatch.com/2017/08/16/journal-retracts-107-papers-fake-reviews-pays-price/
- https://retractionwatch.com/2018/01/19/indexing-company-praises-cancer-journal-kicks/
- https://pubmed.ncbi.nlm.nih.gov/?term=%22Tumour+Biol%22%5Bjour%5D
- Rivera H, Teixeira da Silva JA. Retractions, fake peer review, and paper mills. J Korean Med Sci 2021; 36(24): e165. doi: <a href="https://doi.org/10.3346/jkms.2021.36.e165" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3346/jkms.2021.36.e165</a>
- Teixeira da Silva JA. Conflicts of interest arising from simultaneous service by editors of competing journals or publishers. Publications 2021; 9(1): 6. doi: <a href="https://doi.org/10.3390/publications9010006" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3390/publications9010006</a>
- Zhao T, Dai T, Lun Z, Gao Y. An analysis of recently retracted articles by authors affiliated with hospitals in mainland China. J Schol Publ 2021; 52(2): 107–122. doi: <a href="https://doi.org/10.3138/jsp.52.2.03" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3138/jsp.52.2.03</a>
- Tumor Biology. Retraction notice regarding several articles published in Tumor Biology. Tumor Biol 2021; 43(1): 351–354. doi: <a href="https://doi.org/10.3233/TUB-219010" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.3233/TUB-219010</a>
- Teixeira da Silva JA. Issues and challenges to reproducibility of cancer research: a commentary. Future Oncology 2022; 18(12): 1417–1422. doi: <a href="https://doi.org/10.2217/fon-2021-1378" target="_blank" rel="noopener noreferrer" class="text-signal-blue hover:underline">10.2217/fon-2021-1378</a>
- Errington TM, Mathur M, Soderberg CK et al. Investigating the replicability of preclinical cancer biology. eLife 2021; 10: e71601.
- https://www.isobm.org/about-isobm/history/
Language: English
Page range: 23 - 25
Submitted on: Mar 22, 2022
Accepted on: Apr 17, 2022
Published on: Apr 7, 2022
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year
Keywords:
Related subjects:
© 2022 Jaime A. Teixeira da Silva, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.